Search Results - "ODOM, Jeanne"

Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host Disease by DEAN, Robert M, FRY, Terry, MACKALL, Crystal, STEINBERG, Seth M, HAKIM, Fran, FOWLER, Daniel, ODOM, Jeanne, FOLEY, Jason, GRESS, Ronald, BISHOP, Michael R

“…Morbidity from acute graft-versus-host disease (GVHD) limits the success of allogeneic hematopoietic stem-cell transplantation (HSCT) to treat malignancy…”
Get full text

Age-dependent incidence, time course, and consequences of thymic renewal in adults by Hakim, Frances T., Memon, Sarfraz A., Cepeda, Rosemarie, Jones, Elizabeth C., Chow, Catherine K., Kasten-Sportes, Claude, Odom, Jeanne, Vance, Barbara A., Christensen, Barbara L., Mackall, Crystal L., Gress, Ronald E.

Get full text

Dose-Adjusted EPOCH-Rituximab Combined With Fludarabine Provides an Effective Bridge to Reduced-Intensity Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Lymphoid Malignancies by SALIT, Rachel B, FOWLER, Daniel H, ODOM, Jeanne, BRYANT, Kelly, GRESS, Ronald E, BISHOP, Michael R, WILSON, Wyndham H, DEAN, Robert M, PAVLETIC, Steven Z, DUNLEAVY, Kieron, HAKIM, Frances, FRY, Terry J, STEINBERG, Seth M, HUGHES, Thomas E

“…There is currently no standard chemotherapy regimen for patients with lymphoid malignancies being considered for reduced-intensity conditioning allogeneic…”
Get full text

Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non-Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation by Pollack, Seth M, Steinberg, Seth M, Odom, Jeanne, Dean, Robert M, Fowler, Daniel H, Bishop, Michael R

“…Abstract The hematopoietic cell transplantation comorbidity index (HCT-CI), a weighted index of 17 pretransplantation comorbidities, has been validated in…”
Get full text

Age-dependent incidence, time course, and consequences of thymic renewal in adults by Hakim, Frances T, Memon, Sarfraz A, Cepeda, Rosemarie, Jones, Elizabeth C, Chow, Catherine K, Kasten-Sportes, Claude, Odom, Jeanne, Vance, Barbara A, Christensen, Barbara L, Mackall, Crystal L, Gress, Ronald E

“…Homeostatic regulation of T cells involves an ongoing balance of new T cell generation, peripheral expansion, and turnover. The recovery of T cells when this…”
Get full text

Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas by Bishop, Michael R., Hou, Jeannie Whit-Shan, Wilson, Wyndham H., Steinberg, Seth M., Odom, Jeanne, Castro, Kathleen, Kasten-Sportes, Claude, Gea-Banacloche, Juan, Marchigiani, Donna, Gress, Ronald, Fowler, Daniel H.

“…Reduced-intensity allogeneic hematopoietic stem cell transplantation (alloHSCT), which typically results in mixed chimerism initially after transplantation,…”
Get full text

Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation by Hardy, Nancy M., Fellowes, Vicki, Rose, Jeremy J., Odom, Jeanne, Pittaluga, Stefania, Steinberg, Seth M., Blacklock-Schuver, Bazetta, Avila, Daniele N., Memon, Sarfraz, Kurlander, Roger J., Khuu, Hahn M., Stetler-Stevenson, Maryalice, Mena, Esther, Dwyer, Andrew J., Levine, Bruce L., June, Carl H., Reshef, Ran, Vonderheide, Robert H., Gress, Ronald E., Fowler, Daniel H., Hakim, Frances T., Bishop, Michael R.

“…Donor lymphocyte infusion (DLI), a standard relapse treatment after allogeneic stem cell transplantation (AlloSCT), has limited efficacy and often triggers…”
Get full text

Targeted Lymphocyte Depletion Prior to Reduced Intensity Allogeneic Stem Cell Transplantation: A Personalized Approach to Facilitate Engraftment by Salit, Rachel B., Steinberg, Seth, Fowler, Daniel H., Odom, Jeanne, Bryant, Kelly, Bishop, Michael R.

“…Abstract 865 Reduced intensity allogeneic stem cell transplantation (RIST) is associated with decreased transplant-related mortality (TRM), broadening the pool…”
Get full text

Targeted Lymphocyte Depletion: A Personalized Approach to Achieve Rapid Complete Donor Chimerism and Enhance Graft-Versus-Tumor Effects Following Reduced Intensity Allogeneic Stem Cell Transplantation for High-Risk Hematologic Malignancies by Salit, Rachel B., Steinberg, Seth, Fowler, Daniel H., Odom, Jeanne, Bryant, Kelly, Bishop, Michael R.

“…Abstract 656 Reduced intensity allogeneic stem cell transplantation (RIST) is associated with decreased transplant-related mortality (TRM), broadening the pool…”
Get full text

Concurrent Fludarabine and Cyclophosphamide As a Reduced Intensity Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation Ablates Host T-Cells and Results in Rapid Full Donor Chimerism by Salit, Rachel B., Bishop, Michael R., Pavletic, Steven Z., Hakim, Frances T., Steinberg, Seth M., Odom, Jeanne, Bryant, Kelly, Wilder, Jennifer, Avila, Daniele N., Blacklock-Schuver, Bazetta, Gress, Ronald E., Fowler, Daniel H.

“…Abstract 1937▪▪This icon denotes a clinically relevant abstract Reduced intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (HSCT)…”
Get full text

Correlation of pretransplant and early post‐transplant response assessment with outcomes after reduced‐intensity allogeneic hematopoietic stem cell transplantation for non‐Hodgkin's lymphoma by Bishop, Michael R., Dean, Robert M., Steinberg, Seth M., Odom, Jeanne, Pollack, Seth M., Pavletic, Steven Z., Sportes, Claude, Gress, Ronald E., Fowler, Daniel H.

“…BACKGROUND: Chemotherapy sensitivity, defined simply as at least a partial response to chemotherapy, is an important outcome predictor for non‐Hodgkin lymphoma…”
Get full text

Allogeneic Hematopoetic Transplantation for CLL: Results of Combination Chemotherapy as Pre-Transplant Targeted Lymphocyte Depletion on Disease Response, Donor Chimerism, and Transplantation Outcomes by Shaffer, Brian C, Modric, Marko, Liewehr, David, Stetler-Stevenson, Maryalice, Arthur, Diane C, Steinberg, Seth, Hakim, Frances T, Bryant, Kelly, Odom, Jeanne, Layton, Paula, Salit, Rachel B, Rader, Christoph, Gress, Ronald E, Fowler, Daniel H, Bishop, Michael R, Pavletic, Steven Z

“…Abstract 3476 The development of reduced intensity conditioning (RIC) regimens has increased the use of allogeneic hematopoietic stem cell transplantation…”
Get full text

EPOCH-F: A Novel Salvage Regimen for Multiple Myeloma Prior to Reduced-Intensity Allogeneic Stem Cell Transplantation by Jamshed, Saad, Fowler, Daniel, Neelapu, Sattva, Dean, Robert M., Steinberg, Seth M, Odom, Jeanne, Snow, Kelly, Gress, Ronald E, Bishop, Michael R

“…Variation in baseline host immune status contributes to inconsistent donor engraftment and may impede maximal graft-versus-myeloma effects after…”
Get full text

Burden of Illness in Chronic Graft vs. Host Disease - A Prospective Cohort Study by Pusic, Iskra, Dickinson, John, Steinberg, Seth, Odom, Jeanne, Atlam, Niveen, Mitchell, Sandra, Avila, Daniele, Krumlauf, Michael, Baird, Kristin, Pavletic, Steven

“…BACKGROUND: Chronic Graft vs. Host Disease (cGVHD) is a complex and prevalent complication in long term survivors after allogeneic stem cell transplant. The…”
Get full text

Elevated Serum Interleukin-7 Levels Precede the Development of Acute Graft-Versus-Host Disease by Dean, Robert M., Fry, Terry, Mackall, Crystal, Steinberg, Seth M., Hakim, Frances T., Fowler, Daniel H., Odom, Jeanne, Foley, Jason, Gress, Ronald E., Bishop, Michael R.

“…BACKGROUND: Despite advances in transplantation immunology, there is no clinically practical tool to predict acute graft-versus-host disease (aGVHD) after…”
Get full text

Ex-Vivo Reduction of Allograft T Cell Dose Does Not Prevent Acute Graft-vs-Host Disease after Reduced-Intensity Hematopoietic Stem Cell Transplantation by Hardy, Nancy M., Hakim, Frances, Steinberg, Seth, Krumlauf, Michael, Babb, Rebecca, Odom, Jeanne, Fowler, Daniel, Gress, Ronald, Bishop, Michael R.

“…Allograft T cell depletion (TCD) reduces acute graft-vs. host disease (aGVHD) after myeloablative hematopoietic stem cell transplantation (HSCT). Lower…”
Get full text

Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease by Fowler, Daniel H, Foley, Jason, Whit-Shan Hou, Jeannie, Odom, Jeanne, Castro, Kate, Steinberg, Seth M, Gea-Banacloche, Juan, Kasten-Sportes, Claude, Gress, Ronald E, Bishop, Michael R

“…Gut graft-versus-host disease (GVHD) contributes significantly to lethality after allogeneic hematopoietic stem-cell transplantation (HSCT). In murine models,…”
Get more information

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma by Welles, L, Saville, M W, Lietzau, J, Pluda, J M, Wyvill, K M, Feuerstein, I, Figg, W D, Lush, R, Odom, J, Wilson, W H, Fajardo, M T, Humphrey, R W, Feigal, E, Tuck, D, Steinberg, S M, Broder, S, Yarchoan, R

“…To investigate the antitumor activity and safety of paclitaxel in patients with advanced human immunodeficiency virus (HIV)-associated Kaposi's sarcoma (KS)…”
Get more information

Safety and Efficacy of Cytotoxic Chemotherapy after Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Hematologic Malignancy by Hardy, Nancy M., Odom, Jeanne, Snow, Kelly, Dean, Robert, Pavletic, Steven, Sportes, Claude, Gress, Ronald, Fowler, Daniel H., Bishop, Michael R.

“…Relapse of hematologic malignancy is a major problem after allogeneic hematopoietic stem cell transplantation (alloHSCT), with limited treatment options of…”
Get full text

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST) by Dean, Robert M., Fowler, Daniel, Wilson, Wyndham H., Hakim, Frances, Steinberg, Seth, Odom, Jeanne, Chow, Catherine, Sportes, Claude, Gea-Banacloche, Juan, Pavletic, Steven Z., Hardy, Nancy M., Gress, Ronald, Bishop, Michael R.

“…Reduced-intensity conditioning is less potently tumoricidal than myeloablative regimens; thus, RIST relies more upon graft-versus-tumor (GVT) effects for…”
Get full text